A Complete Genomic Data Platform for Clinical Excellence

Frameshift was created by members of the Molecular Tumor Board at Duke University to optimize patient-centered precision cancer medicine by connecting patients to treatment with real-time decision support.

Data Normalization

  • Frameshift standardizes genomic testing data from vendors like Foundation, Guardant, and Caris

  • Creates unified data format for consistent analysis

  • Eliminates data silos between testing platforms

Robust Searching & Filtering

  • Enables complex queries across normalized genomic data

  • Allows filtering by multiple parameters simultaneously

  • Supports rapid identification of relevant patient cohorts based on molecular signature, demographics, and other health information

Patient Case Presentation

  • Facilitates collaborative review of patient profiles for Molecular Tumor Board (MTB) review meetings

  • Supports multidisciplinary team discussions

  • Enables knowledge sharing across clinical teams

Empower researchers, providers, and molecular tumor boards

  • Clinical researchers can easily look up patients by genetic mutation and other criteria to find every potentially qualified patient within the hospital system, and match them with available clinical trials.

  • Providers can receive real-time notifications when results become available that can guide patient care, inform follow-ups, and improve outcomes.

  • Molecular Tumor Boards (MTBs) can use Frameshift to aid in case selection, case presentation, decision documentation, follow-ups, and tracking outcomes. Preparing for meetings is more efficient, and discussions are more collaborative.

Chart comparing an EHR with Frameshift to a basic EHR and an EHR with a genomics module

Extend your EHR with Frameshift and unlock high-powered insights

Frameshift integrates with your EHR to help make your molecular data more accessible, searchable, and actionable, to foster precision oncology within your institution.

Gain access to real-world clinic-genomic data

AACR Project GENIE has collected genomic data from over 80,000 patients with advanced or rare cancers, making it one of the largest cancer genomic datasets available. Frameshift empowers you to:

  • Seamlessly integrate with AACR Project GENIE, the largest publicly accessible cancer registry of real-world clinic-genomic data

  • Save hours of tedious manual work by easily downloading and uploading data for Project GENIE

  • Improve patient care and outcomes by utilizing the wealth of real-world data available through Project GENIE

Tap into this vast pool of knowledge to drive better patient outcomes.

Medical provider viewing medical data on a tablet